From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework.
about
Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients.Characterizing Class-Specific Exposure-Viral Load Suppression Response of HIV Antiretrovirals Using A Model-Based Meta-Analysis.Model based design and analysis of phase II HIV-1 trials.
P2860
From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@en
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@nl
type
label
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@en
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@nl
prefLabel
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@en
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@nl
P2860
P1476
From in vitro EC₅₀ to in vivo ...... se model. Part I: a framework.
@en
P2093
Pravin R Jadhav
P2860
P2888
P304
P356
10.1007/S10928-012-9255-3
P577
2012-06-27T00:00:00Z